Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid weight loss. Ozempic is for t ...
This came after the drug major Sun Pharma Laboratories presented the proposal to conduct Phase III clinical trial titled “A ...
Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...
An expert in gout clinical trials questions whether ethical considerations for such trials need updating to emphasize patient ...
Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...
Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...
What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.
Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in ...
About ORLADEYO ® (berotralstat) ORLADEYO ® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 ...
In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...
Terns Pharmaceuticals has shelved its oral GLP-1 obesity candidate after a phase 2 trial delivered a mix of weight loss and ...
The intervention being tested is the drug Etelcalcetide, which is administered intravenously. It is designed to manage secondary hyperparathyroidism by controlling levels of intact parathyroid hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback